← Leaderboards
Lei Liu
Brigham And Women'S Hospital
$2,277,228
Attributed
$6,115,685
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,115,685 · 3
By mechanism
RF1$4,352,115 · 1
R01$1,405,570 · 1
R03$358,000 · 1
Top collaborators
- Jasmeer P Chhatwal2 shared
- Michael S Wolfe2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Dennis J Selkoe$33,298,694
- Michael S Wolfe$15,472,448
- Robert Guy Griffin$50,571,740
- Malcolm A Leissring$5,920,046
- Mel B Feany$26,965,920
Others in their field
Other Emerging Leaders on “S Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$249,760,384
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$220,039,059
- Kimberly Smith · Ppd Development Lp$115,671,664
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Research focus
S DiseaseAlzheimer&AposCellsResponseAmyloid Beta-ProteinKineticsEventGamma SecretaseIn VitroNeuronsMembraneTherapeutic DevelopmentBiologicalBiochemicalAbeta SynthesisBaseSecretaseEnzyme SubstrateComplexAffinity ChromatographyAutosomal Dominant Alzheimer&AposBiomarker DevelopmentAmyloid Precursor Protein ProcessingAlpha Secretase
Grant awards (4)
Leveraging Heterogeneity in Autosomal Dominant AD to Elucidate Pathophysiology and Improve AD Biomarkers$1,405,570
R01 · FY2025 · AG
Leveraging Heterogeneity in Autosomal Dominant AD to Elucidate Pathophysiology and Improve AD Biomarkers$4,352,115
RF1 · FY2022 · AG
A previously unrecognized β/γ-secretases complex as a therapeutic target for AD$179,000
R03 · FY2020 · AG · contact PI
A previously unrecognized β/γ-secretases complex as a therapeutic target for AD$179,000
R03 · FY2019 · AG · contact PI